Article
Omeprazole and cardiovascular risk via induction of statin dysmetabolism
2024-10-16
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Statins are a first line treatment for reducing cardiovascular risk. While drug-drug interactions which cause symptomatic side effects are well known, drug- drug interactions which decrease statin effectiveness are poorly understood. <h4>Methods</h4> A multicentre prospective observational study of 1362 participants on chronic statin medication underwent quantitative mass spec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4d4a2948-375b-506f-a774-cad0978d2409
- DOI
- 10.1101/2024.10.14.24315493
